Cargando…

SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model

SARS-CoV-2 and its emerging variants of concern remain a major threat for global health. Here we introduce an infection model based upon polarized human Alveolar Epithelial Lentivirus immortalized (hAELVi) cells grown at the air–liquid interface to estimate replication and epidemic potential of resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mache, Christin, Schulze, Jessica, Holland, Gudrun, Bourquain, Daniel, Gensch, Jean-Marc, Oh, Djin-Ye, Nitsche, Andreas, Dürrwald, Ralf, Laue, Michael, Wolff, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610361/
https://www.ncbi.nlm.nih.gov/pubmed/36302956
http://dx.doi.org/10.1038/s42003-022-04068-3
_version_ 1784819250142117888
author Mache, Christin
Schulze, Jessica
Holland, Gudrun
Bourquain, Daniel
Gensch, Jean-Marc
Oh, Djin-Ye
Nitsche, Andreas
Dürrwald, Ralf
Laue, Michael
Wolff, Thorsten
author_facet Mache, Christin
Schulze, Jessica
Holland, Gudrun
Bourquain, Daniel
Gensch, Jean-Marc
Oh, Djin-Ye
Nitsche, Andreas
Dürrwald, Ralf
Laue, Michael
Wolff, Thorsten
author_sort Mache, Christin
collection PubMed
description SARS-CoV-2 and its emerging variants of concern remain a major threat for global health. Here we introduce an infection model based upon polarized human Alveolar Epithelial Lentivirus immortalized (hAELVi) cells grown at the air–liquid interface to estimate replication and epidemic potential of respiratory viruses in the human lower respiratory tract. hAELVI cultures are highly permissive for different human coronaviruses and seasonal influenza A virus and upregulate various mediators following virus infection. Our analysis revealed a significantly reduced capacity of SARS-CoV-2 Omicron BA.1 and BA.2 variants to propagate in this human model compared to earlier D614G and Delta variants, which extends early risk assessments from epidemiological and animal studies suggesting a reduced pathogenicity of Omicron.
format Online
Article
Text
id pubmed-9610361
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96103612022-10-28 SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model Mache, Christin Schulze, Jessica Holland, Gudrun Bourquain, Daniel Gensch, Jean-Marc Oh, Djin-Ye Nitsche, Andreas Dürrwald, Ralf Laue, Michael Wolff, Thorsten Commun Biol Article SARS-CoV-2 and its emerging variants of concern remain a major threat for global health. Here we introduce an infection model based upon polarized human Alveolar Epithelial Lentivirus immortalized (hAELVi) cells grown at the air–liquid interface to estimate replication and epidemic potential of respiratory viruses in the human lower respiratory tract. hAELVI cultures are highly permissive for different human coronaviruses and seasonal influenza A virus and upregulate various mediators following virus infection. Our analysis revealed a significantly reduced capacity of SARS-CoV-2 Omicron BA.1 and BA.2 variants to propagate in this human model compared to earlier D614G and Delta variants, which extends early risk assessments from epidemiological and animal studies suggesting a reduced pathogenicity of Omicron. Nature Publishing Group UK 2022-10-27 /pmc/articles/PMC9610361/ /pubmed/36302956 http://dx.doi.org/10.1038/s42003-022-04068-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Mache, Christin
Schulze, Jessica
Holland, Gudrun
Bourquain, Daniel
Gensch, Jean-Marc
Oh, Djin-Ye
Nitsche, Andreas
Dürrwald, Ralf
Laue, Michael
Wolff, Thorsten
SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
title SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
title_full SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
title_fullStr SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
title_full_unstemmed SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
title_short SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
title_sort sars-cov-2 omicron variant is attenuated for replication in a polarized human lung epithelial cell model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610361/
https://www.ncbi.nlm.nih.gov/pubmed/36302956
http://dx.doi.org/10.1038/s42003-022-04068-3
work_keys_str_mv AT machechristin sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel
AT schulzejessica sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel
AT hollandgudrun sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel
AT bourquaindaniel sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel
AT genschjeanmarc sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel
AT ohdjinye sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel
AT nitscheandreas sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel
AT durrwaldralf sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel
AT lauemichael sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel
AT wolffthorsten sarscov2omicronvariantisattenuatedforreplicationinapolarizedhumanlungepithelialcellmodel